HBW Regulatory News: Canadian OTC Firm Warned On GMPs, Homeopathic Guidance Comment Extended

FDA says Apollo Health And Beauty Care isn't meeting GMP requirements; and comment period on FDA draft guidance for oversight of homeopathic industry extended through March 23.

Apollo baby line
Apollo Health And Beauty Care's line of products that the FDA says are made in procedures non-compliant with drug GMp reuqirements include children's anad baby soaps, shampoos, sanitizers and bubble baths.

Canadian contract manufacturer Apollo Health And Beauty Care Inc. promotes itself as a personal care product provider but the US Food and Drug Administration considers its products OTC drugs and says the firm isn't meeting good manufacturing practices requirements. In a warning letter published 7 January following an inspection in August, the FDA Center for Drug Evaluation and Research's offices of manufacturing quality and compliance instructed the North York, ON, firm to provide information including results from a comprehensive investigation into the extent of the inaccuracies in its data records and reporting, including results of review for drugs distributed to the US and a detailed description of the scope and root causes of its data integrity lapses; and a current risk assessment of the potential effects of the observed failures on the quality of its drugs, including "analyses of the risks to patients caused by the release of drugs affected by a lapse of data integrity and analyses of the risks posed by ongoing operations."

The warning submitted on 23 December, after the firm's response submitted in September failed to state details on corrective...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

US FDA Extracts More Evidence To Ban Kratom

 

Recent warning letters to seven companies marketing products with kratom extract known as 7-OH are FDA’s first in three years referencing unlawful products containing kratom and the first of all its kratom-related warnings to reference extracts from the botanical.

Cloudy Tariff Conditions Expected To Linger In US

 

White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.

US FDA Has Lists To Assure Progress On Supplement Sector Regulations, NDIN Guidance

 

The agency says items on its Human Foods Program’s proposed agenda for guidance “to complete during 2025” include identity and safety information for NDI notifications. Its announcement also links to document about a separate key industry question, a rulemaking which would recognize NAC as a lawful

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.

More from Policy & Regulation

UK FSA Issues New Guidelines For CBD And THC Max Levels

 
• By 

Based on advice from its advisory committees, the UK's Food Standards Agency is encouraging businesses to meet an acceptable daily intake of 10mg CBD per day and a safe upper limit of 0.07mg THC per day.

US FDA Has Lists To Assure Progress On Supplement Sector Regulations, NDIN Guidance

 

The agency says items on its Human Foods Program’s proposed agenda for guidance “to complete during 2025” include identity and safety information for NDI notifications. Its announcement also links to document about a separate key industry question, a rulemaking which would recognize NAC as a lawful

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.